Canada · Delayed Price · Currency is CAD Aptose Biosciences Statistics
Total Valuation
TSX:APS has a market cap or net worth of CAD 4.03 million. The enterprise value is 18.79 million.
| Market Cap | 4.03M |
| Enterprise Value | 18.79M |
Important Dates
The last earnings date was Thursday, August 7, 2025.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:APS has 2.55 million shares outstanding. The number of shares has increased by 337.23% in one year.
| Current Share Class | 2.55M |
| Shares Outstanding | 2.55M |
| Shares Change (YoY) | +337.23% |
| Shares Change (QoQ) | +20.04% |
| Owned by Insiders (%) | 0.32% |
| Owned by Institutions (%) | 3.91% |
| Float | 2.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.21 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.65 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.51 |
Financial Position
The company has a current ratio of 0.36
| Current Ratio | 0.36 |
| Quick Ratio | 0.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.42 |
| Interest Coverage | -53.70 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -162.74% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 631.68% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.22M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +233.52% in the last 52 weeks. The beta is 1.02, so TSX:APS's price volatility has been similar to the market average.
| Beta (5Y) | 1.02 |
| 52-Week Price Change | +233.52% |
| 50-Day Moving Average | 1.79 |
| 200-Day Moving Average | 1.81 |
| Relative Strength Index (RSI) | 48.03 |
| Average Volume (20 Days) | 3,952 |
Short Selling Information
The latest short interest is 6,975, so 0.04% of the outstanding shares have been sold short.
| Short Interest | 6,975 |
| Short Previous Month | 10,084 |
| Short % of Shares Out | 0.04% |
| Short % of Float | 0.05% |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -29.37M |
| Pretax Income | -28.81M |
| Net Income | -28.81M |
| EBITDA | -29.35M |
| EBIT | -29.37M |
| Earnings Per Share (EPS) | -17.78 |
Balance Sheet
The company has 754,215 in cash and 15.51 million in debt, giving a net cash position of -14.76 million or -5.78 per share.
| Cash & Cash Equivalents | 754,215 |
| Total Debt | 15.51M |
| Net Cash | -14.76M |
| Net Cash Per Share | -5.78 |
| Equity (Book Value) | -19.60M |
| Book Value Per Share | -7.68 |
| Working Capital | -7.81M |
Cash Flow
In the last 12 months, operating cash flow was -37.06 million and capital expenditures -6,819, giving a free cash flow of -37.07 million.
| Operating Cash Flow | -37.06M |
| Capital Expenditures | -6,819 |
| Free Cash Flow | -37.07M |
| FCF Per Share | -14.52 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSX:APS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -337.23% |
| Shareholder Yield | n/a |
| Earnings Yield | -714.39% |
| FCF Yield | -919.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 26, 2025. It was a reverse split with a ratio of 0.0333333.
| Last Split Date | Feb 26, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0333333 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |